With synthetic mesh now largely withdrawn, and native tissue repair alone associated with high recurrence rates, clinicians have been left with limited tools to support prolapse repair.
SmartFem exists to fill that gap, offering a graft solution that is:
Help designed in collaboration with leading Australian clinicians, we work with healthcare professionals who share a commitment to advancing pelvic floor surgery and improving the outcome experience for women.
SmartFem provides the Victoria Graft System, an intraoperative autologous graft solution. It is:
The system follows a known Class IIa regulatory pathway and is manufactured under clinical conditions to support adoption in both private and public hospitals.
SmartFem’s development pathway has been deliberate and data-informed of preliminary findings:
Proof of concept demonstrated in 100+ patients
Clinical use in >100 women with over 85% showing successful support at 12 months
More than 400 patients treated with no reported adverse events
Product launch and new independent clinical evaluations underway.
Our filed patent, “Scaffold for soft tissue augmentation and reinforcement”, covers the core technology and is undergoing submission in key global markets.
Founder and Chief Medical Officer
PHD, MD, MMIS, FRANZCOG
Dr Fariba Behnia‑Willison is a fully accredited gynaecological surgeon and pioneer in female pelvic regenerative treatment, such as the use of PRP. She introduced single-incision laparoscopic techniques to Australia and performed the world’s first single-incision mesh hysteropexy.
Operations Manager
BE, MEng, PhD
Dr Pouria Aryan is a biomedical engineer and research manager with extensive experience across both industry and academia. He specialises in translating engineering innovation into clinically meaningful, patient-centred solutions. With a background spanning mechanical engineering, and biomedical research, Dr Aryan brings a unique interdisciplinary perspective to the development and implementation of advanced medical technologies.
Research Manager
BMid, MMid, PhD (Reproductive health)
Dr Mahshid Taheri is a clinical researcher with a strong background in clinical trials, data analysis, and medical writing. She leads SmartFem’s research and clinical affairs, supporting evidence generation, ethics approvals, and post-market surveillance activities for the VGS. With a focus on scientific integrity and regulatory alignment, Mahshid ensures that SmartFem’s clinical strategy is robust, ethical, and aligned with global best practices in women’s health innovation.
We welcome conversations with:
